The mRNA levels of heregulin normalized to the β-actin levels in specimens before and after trastuzumab-based therapy were assessed in 8 breast cancer patients and 2 gastric cancer patients (Table 1, Figure 6). This evidence concerns the gene ACTB and breast carcinoma.